Delivery Order SPE2DB20D3101-SPE2DB25FRSZ3
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,290.32 for the supply of Loperamide HCL 500mg capsules on August 15, 2025. This firm fixed-price contract, which is not set-aside and competitively awarded, is scheduled for completion by August 18, 2025. The contract is funded through the Defense Logistics Agency's Medical Supply Chain, a defense agency component, with the place of performance at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 capsules of Loperamide 2 mg, valued at $1,074.23, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with...
- The U.S. Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Loperamide 2 mg capsules in quantities of 100 units. This firm fixed-price delivery order, valued at $1,596.00, is scheduled for completion by August 11, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside designation and represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,088.65 to AmerisourceBergen Drug Corp for Loperamide 2 mg capsules in unit-dose packaging of 100 units. This competitively awarded, firm fixed-price contract was executed on July 21, 2025, with an ultimate completion date of July 22, 2025. The contract carries no set-aside designation and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This federal contract award, SPE2DB22D3301|SPE2DB25FY3XK, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,501.99 firm fixed-price delivery order is for the supply of 4,568,053,642 units of the pharmaceutical product Loperamide 2 mg capsules. The contract has an ultimate completion date of April 29, 2025 and does not utilize any set-aside designation, indicating open competition....
- The Defense Logistics Agency Medical Supply Chain awarded a $14.7K delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of 500 units of Loperamide 2mg tablets, with completion scheduled for September 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract valued at $1,173.52 by the Defense Logistics Agency's Medical Supply Chain on August 12, 2025. This firm fixed-price delivery order, which represents a child award under a larger contract vehicle, carries an ultimate completion date of August 13, 2025. The contract was competitively awarded with no set-aside designation and utilizes...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $42,325.67 on August 11, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed price contract, with an ultimate completion date of August 12, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX. The award was made through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $37,470.85 by the Defense Logistics Agency's Medical Supply Chain on August 11, 2025. This firm fixed-price contract represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award is non-competitive and scheduled for ultimate...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,447.28 by the Defense Logistics Agency's Medical Supply Chain on July 31, 2025, with an ultimate completion date of August 1, 2025. This firm fixed-price contract represents a child delivery order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRSZ3Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 19, 2025, for the supply of Loperamide 2 mg capsules (100 count) with a ceiling value of $1,067.84. This firm fixed-price delivery order represents a non-competitive award and is scheduled for completion by August 20, 2025, with performance occurring at the vendor's Conshohocken location. The award is classified as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp serves as a critical federal pharmaceutical vendor for military and veteran healthcare systems, supplying a comprehensive range of medications and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. The company's federal procurement portfolio demonstrates extensive experience fulfilling diverse medical supply requirements through competitively awarded delivery orders under the DLA's pharmaceutical support framework. This particular delivery order aligns with the Defense Logistics Agency's mission to provision pharmaceutical commodities across the military healthcare supply chain and supports the broader Pharmaceutical Prime Vendor Global Program supporting worldwide military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/19/25 |